Latest news

Commercial

The biggest pharmaceutical deal ever would be the “unlikely” AstraZeneca-BMS mega-merger

Word spread that two big pharma players, Bristol Myers Squibb and AstraZeneca, each valued at more than $130 billion,...
Commercial

Supernus and Indivior Agree to Create CNS-Focused Company in All-Stock Merger

Supernus Pharmaceuticals and Indivior Pharmaceuticals have agreed to combine in an all-stock merger that will create a central nervous...
Insights

From Data-Rich to Insight-Rich: Pharma’s Next Transformation

Executive Summary The pharmaceutical industry has become one of the most data-intensive industries in the world. Every stage of the pharmaceutical...
Commercial

Hinge Health to Buy Out Cylinder Health in a Deal Worth Over $100M

Hinge Health has agreed to acquire digital gastrointestinal care startup Cylinder Health as the company expands its platform beyond...
Clinical

Merck’s Tulisokibart Misses Phase 2 Endpoint in SSc-ILD but Meets Goals in HS Trial

Merck & Co. has reported mixed clinical results for...
Insights

The New Competitive Advantage in Biopharma Isn’t Science Alone

Executive Summary For decades, scientific innovation has been the defining...
Insights

Why Protocol Complexity Continues to Threaten Trial Success

Executive Summary Clinical trials remain the foundation of pharmaceutical innovation, but their increasing complexity has become one of the industry's...
Regulatory

FDA Grants Full Approval to Fabhalta for IgA Nephropathy

Novartis has received full approval from the U.S. Food and Drug Administration (FDA ) for Fabhalta to treat adults...
Clinical

After phase 3 data ended blockbuster hopes, GSK eliminated a major cough medication candidate

Analysis of the phase 3 results on camlipixant, which was a major potential blockbuster expected to be the standout...
Commercial

Dimerix Acquires Phase 2-Ready AKI Drug DMX-652 From Mission Therapeutics

Dimerix has acquired DMX-652, a phase 2-ready drug candidate...
Insights

Top 10 Strategic Priorities for Pharmaceutical Leaders in 2026

Executive Summary The pharmaceutical industry is entering a period of...
Insights

Why Data Quality Is Becoming Pharma’s Biggest AI Challenge

Executive Summary Artificial intelligence (AI) has become one of the pharmaceutical industry's most important strategic priorities. Companies are investing heavily in...
Commercial

Lilly challenges J&J in the market for psychedelic mental health by paying $2.8 billion up front for AtaiBeckley

Eli Lilly has inked the deal to purchase AtaiBeckley for $2.8 billion to continue its acquisition spree in a...
Insights

The Next Wave of Innovation in Oncology

Executive Summary Oncology remains one of the most dynamic and rapidly evolving areas of pharmaceutical innovation. Over the past two decades,...
Regulatory

FDA Grants Full Approval to Fabhalta for IgA Nephropathy

Novartis has received full approval from the U.S. Food...
Editorial Team -
Commercial

Argenx and Unnatural Products Sign $1.5 Billion Deal to Develop Macrocyclic Peptide Therapies

Argenx has entered into an agreement with California-based Unnatural...
Commercial

$1.5 Billion Cancer Drug Facility to Be Built by AstraZeneca in Singapore

AstraZeneca is reportedly planning to build a $1.5 billion...

Popular

Most popular life news you must read today

View all articles

Commercial

Information Technology

Claryx Appears From Stealth to Deal with the $45B Hospital-Acquired Infections Issue

Healthcare-related infections remain a persistent challenge for hospitals, affecting roughly one in every 40...
Editorial Team -

J&J’s OTTAV Robotic Surgical System has received FDA market authorization in the U.S.

The U.S. Food and Drug Administration (FDA) granted Johnson & Johnson De Novo clearance...
Editorial Team -

Alnylam Inks $2B Agreement With Inceptive to Change sIRNA Design With AI Leader

Alnylam has entered into a partnership with the scientist instrumental in developing the technology...
Editorial Team -

Chugai and Gero Partner to Develop Antibodies for Age-Related Diseases Using AI

Chugai Pharmaceutical has entered into a research collaboration with Singapore-based Gero to develop antibody-based...
Editorial Team -

Regulatory

Regulatory

FDA Grants Full Approval to Fabhalta for IgA Nephropathy

Novartis has received full approval from the U.S. Food...
Editorial Team -
Commercial

Supernus and Indivior Agree to Create CNS-Focused Company in All-Stock Merger

Supernus Pharmaceuticals and Indivior Pharmaceuticals have agreed to combine...
Insights

From Data-Rich to Insight-Rich: Pharma’s Next Transformation

Executive Summary The pharmaceutical industry has become one of the...
Commercial

Hinge Health to Buy Out Cylinder Health in a Deal Worth Over $100M

Hinge Health has agreed to acquire digital gastrointestinal care...
Technology

Claryx Appears From Stealth to Deal with the $45B Hospital-Acquired Infections Issue

Healthcare-related infections remain a persistent challenge for hospitals, affecting...

Research & Development

Market Access

Manufacturing

Avalyn Files for IPO Targeting Up to $209.7 Million to Advance Inhaled Lung Therapies

Avalyn Pharma, a Boston-based company focused on inhaled therapies...
Manufacturing

Replimune Cuts 224 Jobs in Massachusetts After Second FDA Rejection of RP1

Replimune is reducing its workforce by 224 employees across...

Manufacturing & RegulatoryPOPULAR
Find Your Perfect Music Festival

Insights

From Data-Rich to Insight-Rich: Pharma’s Next Transformation

Executive Summary The pharmaceutical industry has become one of the...
Editorial Team -